Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome

Fertility and Sterility

Volumn 91, Issue 5, 2009, Pages 1848-1852

  Brennan, Kathleen ^a   Huang, Andy ^a   Azziz, Ricardo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

adrenal androgens; DHEAS; insulin resistance; Polycystic ovary syndrome (PCOS)

Indexed keywords

ANDROGEN; HYDROXYPROGESTERONE; INSULIN; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; THYROID HORMONE;

ADULT; ARTICLE; BODY MASS; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL; WAIST HIP RATIO;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; BODY MASS INDEX; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; WAIST-HIP RATIO;

EID: 67349112145     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.02.101     Document Type: Article

References (35)

1. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
2. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., Filandra F.A., Tsianateli T.C., Spina G.G., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: a hormonal and metabolic profile. J Clin Endocrinol Metab 84 (1999) 4006-4011
3. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., and Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85 (2000) 2434-2438
4. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., and Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 (2004) 2745-2749
5. DeUgarte C.M., Bartolucci A.A., and Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83 (2005) 1454-1460
6. Yucel A., Noyan V., and Sagsoz N. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 126 (2006) 81-86
7. Barbieri R., Makris A., Randall R.W., Daniels G., Kistner R.W., and Ryan K.J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62 (1986) 904-910
8. Nestler H.E., Jakubowicz D.J., de Vargas A.F., Brik C., Quintero N., and Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositol-glycan mediators as the signal transduction system. J Clin Endocrinol Metab 83 (1998) 2001-2005
9. Buyalos R.P., Bradley Jr. E.L., Judd H.L., Zacur H.A., and Azziz R. No acute effect of physiologic insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease. Fertil Steril 56 (1991) 1179-1182
10. Hines G.A., Smith E.R., and Azziz R. Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies. Fertil Steril 76 (2001) 730-735
11. Yamashita R., Saito T., Satoh S., Aoki K., Kuburagi Y., and Sekihara H. Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2. Endocrinol J 52 (2005) 727-733
12. Buffington C.K., Given J.R., and Kiabchi A.E. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females. Diabetes 40 (1991) 693-700
13. Mottl R., and Cerman J. A relationship between dehydroepiandrosterone sulfate and insulin resistance in obese men and women. Vnitr Lek 50 (2004) 923-929
14. Barrett-Connor K., Khaw K.T., and Yen S.S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315 (1986) 1519-1524
15. Mitchell L.E., Sprecher D.L., Borecki I.B., Rice T., Laskarzewki P.M., and Rao D.C. Evidence for an association between dehydroepiandrosterone sulfate and nonfatal premature myocardial infarction in males. Circulation 89 (1994) 89-93
16. Feldman H.A., Johannes C.B., Arauajo A.B., Mohr B.A., Longcope C., and McKinay J.B. Low dehydroepiandrosterone and ischemic heart diseases in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 153 (2001) 79-89
17. Kameda W., Daimon M., Oizumi T., Jimbu Y., Kimura M., Hirata A., et al. Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the Fungata Study. Metabolism 54 (2005) 669-676
18. Orentreich N., Brind H.L., Rixer R.L., and Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59 (1984) 551-555
19. Fink R.I., Kolterman O.G., Griffin J., and Olefsky J.M. Mechanism of insulin resistance in aging. J Clin Invest 71 (1983) 1523-1535
20. Rowe J.W., Minaker K.L., Pallotta H.A., and Flier J.S. Characterization of the insulin resistance in aging. J Clin Invest 71 (1983) 1581-1587
21. Paolisso G., Ammendola S., Rotandi M., Gambardella A., Rizzo M.R., Mazziotti G., et al. Insulin resistance and advancing age: what role for dehydroepiandrosterone sulfate?. Metabolism 46 (1997) 1281-1286
22. Allolio B., and Arlt W. DHEA treatment: myth or reality?. Trends Endocrinol Metab 13 (2002) 288-294
23. Coleman D.L., Leiter E.H., and Schwizer R.W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31 (1982) 830-833
24. Azziz R. Evaluation for insulin resistance and co-morbidities related to insulin resistance in PCOS. In: Nestler J.E., Diamanti-Kanarakis E., Pasquali R., and Panidis D. (Eds). Insulin resistance and polycystic ovarian syndrome: pathogenesis, evaluation, and treatment (2007), Human Press, New York 145-157
25. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F., and Merriam G.R. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Boston 377-384
26. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
27. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
28. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91 (2006) 4237-4245
29. Hatch R., Rosenfield R.L., Kim M.H., and Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140 (1981) 815-830
30. Azziz R., Bradley Jr. E.L., Potter H.D., Parker Jr. C.R., and Boots L.R. Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women. Am J Obstet Gynecol 172 (1995) 1251-1256
31. Pearlman W.H., Crepy O., and Murphy M. Testosterone-binding levels in the serum of women during the normal menstrual cycle, pregnancy, and the postpartum. J Clin Endocrinol Metab 27 (1967) 1012-1018
32. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
33. Yildiz B.O., and Azziz R. The adrenal and polycystic ovary syndrome. Rev Endocrinol Metab Disord 8 (2007) 331-342
34. Farah-Eways L., Reyna R., Knochenbauer E.S., Bartolucci A.A., and Azziz R. Glucose action and andrenocortical biosynthesis in women with polycystic ovary syndrome. Fertil Steril 81 (2004) 120-125
35. Diamonti-Kandarakis E., Kouli C., Alexandraki K., and Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 1273-1276